Am J Epidemiol

1. RUSSO M, Sreedhara SK, Smith J, Davis SE, et al
   Electronic health record-enhanced signal detection using tree-based scan statistic methods.
   Am J Epidemiol. 2026;195:178-187.
   

   >> Share

   
   
2. POWER GM, Palmer T, Warrington N, Heron J, et al
   A structural mean modelling Mendelian randomization approach to investigate the lifecourse effect of adiposity: applied and methodological considerations.
   Am J Epidemiol. 2025 Feb 17:kwaf029. doi: 10.1093.
   

   >> Share

   
   

   
   Am J Manag Care

3. PATEL BV, Wang SM, Messer LH, Pinsker JE, et al
   HEDIS glycemic goal achieved using control-IQ Technology.
   Am J Manag Care. 2025;31:e357-e363.
   

   >> Share

   
   
4. SHOAIB N, Azhar N, Shoaib M
   GLP-1 receptor agonists: trend, necessity, or blessing?
   Am J Manag Care. 2025;31.
   

   >> Share

   
   
5. PANGRACE M, Albright J, Basta S, Bratcher T, et al
   Exploratory study of selected stakeholder insights into continuous glucose monitoring in T2D with risk-sharing agreements.
   Am J Manag Care. 2025;31.
   

   >> Share

   
   
6. SHENOY DA, Cummins L, Kaplan S, Zullig LL, et al
   Interventions addressing cost-related medication nonadherence in diabetes: a scoping review.
   Am J Manag Care. 2025;31.
   

   >> Share

   
   

   
   Ann Intern Med

7. KRISTENSEN FPB, Christensen DH, Callaghan BC, Nielsen JS, et al
   Effectiveness of Sodium-Glucose Cotransporter-2 Inhibitors Versus Glucagon-like Peptide-1 Receptor Agonists on Diabetic Foot Disease : An Emulated Target Trial.
   Ann Intern Med. 2026 Jan 6. doi: 10.7326/ANNALS-25-01262.
   

   >> Share

   
   

   
   Atherosclerosis

8. MOON S, Hong S, Han K, Park CY, et al
   Effects of cilostazol on the prognosis of lower extremity peripheral arterial disease in patients with diabetes mellitus in Korea: A nationwide population-based study.
   Atherosclerosis. 2025;413:120634.
   

   >> Share

   
   

   
   Biochem Biophys Res Commun

9. ZHANG M, Bi H, Guo D
   Advances in study of endoplasmic reticulum stress in ophthalmic diseases: an overview.
   Biochem Biophys Res Commun. 2026;797:153182.
   

   >> Share

   
   

   
   BMC Ophthalmol

10. MA Z, Yu F, Li H, Liu Y, et al
    Divergent nasal-temporal changes in superficial vascular density as early biomarkers of diabetic retinopathy.
    BMC Ophthalmol. 2026;26:11.
    

    >> Share

    
    
11. SADEGHI R, Abdol Homayuni MR, Fateh A, Ebrahimzadeh N, et al
    The gut-eye axis: microbiota and their role in diabetic retinopathy: a systematic review and meta-analysis.
    BMC Ophthalmol. 2026;26:7.
    

    >> Share

    
    

    
    BMC Pediatr

12. DOKHAN-VURAL S, Kahlert CR, Roduit C, Heldt K, et al
    Health-related quality of life, glycaemic control, lifestyle characteristics and SARS-CoV-2 prevalence in children with type 1 diabetes during the COVID-19 pandemic: results of a longitudinal, prospective single-centre Swiss study.
    BMC Pediatr. 2026 Jan 6. doi: 10.1186/s12887-025-06375.
    

    >> Share

    
    
13. MORADI A, Norouzi M, Farkhani EM
    Impact of gestational weight gain on adverse pregnancy outcomes in women with gestational diabetes: a retrospective cohort study.
    BMC Pediatr. 2026;26:13.
    

    >> Share

    
    

    
    BMJ

14. ALLOTEY J, Coomar D, Ensor J, Ruiz-Calvo G, et al
    Effects of lifestyle interventions in pregnancy on gestational diabetes: individual participant data and network meta-analysis.
    BMJ. 2026;392:e084159.
    

    >> Share

    
    

    
    Diabet Med

15. HAUGVIK S, Hennekes MHCL, de Wit M, Toschi E, et al
    Can the Diabetes Eating Problem Survey-Revised (DEPS-R) reliably identify eating disorder diagnosis in women with type 1 diabetes?
    Diabet Med. 2026 Jan 8:e70207. doi: 10.1111/dme.70207.
    

    >> Share

    
    
16. LEE VY, Donges K, Beech A, Makris A, et al
    Type 2 diabetes after gestational diabetes, a cross-sectional study-DIVINE-NSW.
    Diabet Med. 2026 Jan 9:e70155. doi: 10.1111/dme.70155.
    

    >> Share

    
    
17. DAVIS TME, Davis WA
    Incidence and associates of aortic valve replacement in people with or without type 2 diabetes: The Fremantle diabetes study phase II.
    Diabet Med. 2026 Jan 5:e70211. doi: 10.1111/dme.70211.
    

    >> Share

    
    
18. SUN J, Miao G, Meng C
    Expanding insights on automated insulin delivery and physical activity in type 1 diabetes.
    Diabet Med. 2026 Jan 6:e70213. doi: 10.1111/dme.70213.
    

    >> Share

    
    
19. ZIEGLER J, Neu A, Ehehalt S, Schweizer R, et al
    Age-specific incidence and prevalence of childhood type 1 diabetes: Development over four decades in Southwest Germany.
    Diabet Med. 2026 Jan 6:e70215. doi: 10.1111/dme.70215.
    

    >> Share

    
    
20. ZHU W, Wang H, Xu T, Zhang S, et al
    Burden of type 2 diabetes in Asia-Pacific regions, 1990-2021: GBD 2021 analysis with forecast to 2050.
    Diabet Med. 2026 Jan 6:e70216. doi: 10.1111/dme.70216.
    

    >> Share

    
    
21. SOHOLM U, Thuraisingam S, Holmes-Truscott E, de Zoysa N, et al
    Changes in HbA1c and diabetes-specific quality of life following structured type 1 diabetes education: Exploratory latent profile analysis of outcomes in the DAFNEplus trial.
    Diabet Med. 2026 Jan 8:e70203. doi: 10.1111/dme.70203.
    

    >> Share

    
    

    
    Diabetes

22. KONTIDOU E, Collado A, Humoud R, Manickam K, et al
    Long Duration of Type 2 Diabetes Drives Erythrocyte-Induced Vascular Endothelial Dysfunction: A Link to miRNA-210-3p.
    Diabetes. 2026 Jan 9:db250463. doi: 10.2337/db25-0463.
    

    >> Share

    
    

    
    Diabetes Care

23. HE JH, Wang D, Rooney MR, Wallace AS, et al
    Defining Clinically Interpretable Glycemic Profiles Using Continuous Glucose Monitoring in Type 2 Diabetes.
    Diabetes Care. 2026 Jan 9:dc252633. doi: 10.2337/dc25-2633.
    

    >> Share

    
    
24. FENG Q, Albalak G, Ao L, Xiao Q, et al
    Associations of Moderate-to-Vigorous Physical Activity Timing With Type 2 Diabetes Incidence in UK Biobank and Prevalent Glycemic Measures in NHANES.
    Diabetes Care. 2026 Jan 9:dc252095. doi: 10.2337/dc25-2095.
    

    >> Share

    
    
25. BRODSGAARD RB, Mizrak HI, Brock B, Rossing P, et al
    Vitamin B12 and Neuropathy in Type 1 Diabetes.
    Diabetes Care. 2026 Jan 9:dc252168. doi: 10.2337/dc25-2168.
    

    >> Share

    
    

    
    Diabetes Obes Metab

26. RIVELINE JP, Renard E, Aleppo G, Bode BW, et al
    Psychosocial outcomes among adults with type 1 diabetes using a tubeless automated insulin delivery system compared with sensor augmented pump therapy: A randomised, parallel-group clinical trial sub-study.
    Diabetes Obes Metab. 2026 Jan 8. doi: 10.1111/dom.70416.
    

    >> Share

    
    
27. TAN X, Liang Y, Xie L, Harton J, et al
    Comparison of cardiovascular outcomes between once-weekly semaglutide and dulaglutide in adults with type 2 diabetes and established atherosclerotic cardiovascular disease in the United States.
    Diabetes Obes Metab. 2026 Jan 8. doi: 10.1111/dom.70440.
    

    >> Share

    
    
28. ZAWADKA M, Taguiam E, Le ML, Sanjanwala R, et al
    Sex differences in trial representation and the cardiovascular effectiveness of newer glucose-lowering agents in patients with and without type 2 diabetes: A systematic review and meta-analysis of cardiovascular outcome trials.
    Diabetes Obes Metab. 2026 Jan 8. doi: 10.1111/dom.70411.
    

    >> Share

    
    
29. OH R, Kim S, Cho SH, Kim JY, et al
    Elevated triglyceride-glucose index is associated with increased risk of chronic kidney disease and end-stage renal disease in type 1 diabetes: Nationwide cohort study.
    Diabetes Obes Metab. 2026 Jan 7. doi: 10.1111/dom.70455.
    

    >> Share

    
    
30. HERMANNS N, Kittel P, Cerletti P, Kulzer B, et al
    Independent associations of mental health and diabetes complications with health-related quality of life: Evidence from a cross-sectional study.
    Diabetes Obes Metab. 2026 Jan 7. doi: 10.1111/dom.70434.
    

    >> Share

    
    
31. TONG X, Zhang Y, Zhang L, Zhang L, et al
    Once-weekly insulin icodec versus once-daily insulin degludec for type 2 diabetes in China: A cost-utility and budget impact analysis.
    Diabetes Obes Metab. 2026 Jan 6. doi: 10.1111/dom.70435.
    

    >> Share

    
    
32. KISHIMORI T, Kato T, Iwasaki Y, Shimada T, et al
    Oral semaglutide and survival in heart failure with preserved ejection fraction and type 2 diabetes.
    Diabetes Obes Metab. 2026 Jan 5. doi: 10.1111/dom.70433.
    

    >> Share

    
    
33. CHEN L, Zhang Q, Duan B, Wu X, et al
    Effects of age and disease duration on the glycaemic outcomes and safety of insulin glargine 300 U/mL in people with type 2 diabetes in China: A post-hoc analysis of the INITIATION study.
    Diabetes Obes Metab. 2026 Jan 5. doi: 10.1111/dom.70420.
    

    >> Share

    
    
34. KABYTAEV K, Maddaloni E, Ferm ML, Redondo MJ, et al
    C-peptide as an important biomarker in diabetes management: The need for standardization of its measurement.
    Diabetes Obes Metab. 2026 Jan 5. doi: 10.1111/dom.70447.
    

    >> Share

    
    
35. TAJIMA T, Kaga H, Ito N, Kogai T, et al
    Dual action of imeglimin on insulin secretion and sensitivity in type 2 diabetes.
    Diabetes Obes Metab. 2026 Jan 5. doi: 10.1111/dom.70449.
    

    >> Share

    
    
36. YEO YH, San BJ, Lim GK, Tan MC, et al
    Increasing cardiovascular mortality in young adults with diabetes mellitus as a contributing cause in the United States.
    Diabetes Obes Metab. 2026 Jan 5. doi: 10.1111/dom.70441.
    

    >> Share

    
    
37. MARIGLIANO M, Mozzillo E, Romanelli R, Passanisi S, et al
    Higher post-prandial glucose excursions in youth with type 1 diabetes and celiac disease: Time to change the bolus?
    Diabetes Obes Metab. 2026 Jan 8. doi: 10.1111/dom.70430.
    

    >> Share

    
    
38. GIUGLIANO D, Longo M, Di Martino N, Scappaticcio L, et al
    GLP1-1RAs improve walking distance and reduce amputation in people with type 2 diabetes and peripheral artery disease: A systematic review and meta-analysis of randomised controlled trials and cohort studies.
    Diabetes Obes Metab. 2026 Jan 8. doi: 10.1111/dom.70454.
    

    >> Share

    
    
39. SUGIMOTO T, Omura T, Araki A, Haneda C, et al
    Long-term effects of a multidomain intervention on cognitive function and metabolic control in older adults with type 2 diabetes and mild cognitive impairment: A 42-month follow-up of the J-MIND-Diabetes study.
    Diabetes Obes Metab. 2026 Jan 8. doi: 10.1111/dom.70431.
    

    >> Share

    
    

    
    Diabetologia

40. THOMSON RL, Martin G, McGorm KJ, Spelman T, et al
    Perceived stress in mothers of children with and without islet and coeliac autoimmunity in the ENDIA study.
    Diabetologia. 2026;69:343-349.
    

    >> Share

    
    
41. SMEDEGAARD S, Rittig N, Ovesen PG, Suder LB, et al
    Once-daily supplementation with pre-meal whey protein lowers breakfast postprandial glucose levels in women with GDM throughout the third trimester: a randomised, controlled, clinical trial.
    Diabetologia. 2026;69:350-363.
    

    >> Share

    
    
42. PREFONTAINE C, Pipella J, Rampazzo Morelli N, Chen YC, et al
    Insulin production is sustained during DNA damage-mediated senescence in adult human beta cells.
    Diabetologia. 2026;69:421-435.
    

    >> Share

    
    
43. NAIR AK, Barkho K, Cheranda KP, Traurig M, et al
    Modelling the effects of human SUR1 R1420H variation on insulin secretory function using isogenic iPSC-derived pancreatic islets.
    Diabetologia. 2026;69:399-420.
    

    >> Share

    
    
44. JOING I, Marais G, Huchez A, Lespagnol E, et al
    How adolescents with type 1 diabetes experience physical education in middle school: a qualitative study.
    Diabetologia. 2026 Jan 7. doi: 10.1007/s00125-025-06648.
    

    >> Share

    
    
45. WESTHOLM E, Karagiannopoulos A, Nielsen BU, Shaw JAM, et al
    Dynamic changes in circulating microRNAs during oral glucose tolerance testing support their potential as diagnostic and monitoring biomarkers in cystic fibrosis-related diabetes.
    Diabetologia. 2026 Jan 7. doi: 10.1007/s00125-025-06645.
    

    >> Share

    
    

    
    JAMA

46. MAYA J, Pant D, Fu Y, James K, et al
    Gestational Weight Gain and Pregnancy Outcomes After GLP-1 Receptor Agonist Discontinuation.
    JAMA. 2025 Nov 24:e2520951. doi: 10.1001/jama.2025.20951.
    

    >> Share

    
    

    
    Kidney Int

47. PRUIJM M, Belmar N, Bjornstad P, Cherney DZI, et al
    REMODELing mechanistic trials for kidney disease: a multimodal, tissue-centered approach to understand the renal mechanism of action of semaglutide.
    Kidney Int. 2026;109:6-16.
    

    >> Share

    
    
48. SCHUG AP, Ly LT, Eckardt KU, Balzer MS, et al
    The Case | The sweet twirl-chorea as a diabetic complication: an elderly patient with CKD, hyperglycemia, and chorea.
    Kidney Int. 2026;109:235-236.
    

    >> Share

    
    

    
    Med Care

49. NELSON LA, Bergner EM, Adler A, Yoon C, et al
    Development and Value of a Centralized Text Message-based Tracking and Support Program for the PRECIDENTD Study.
    Med Care. 2026;64.
    

    >> Share

    
    

    
    N Engl J Med

50. BOHULA EA, Marston NA, Bhatia AK, De Ferrari GM, et al
    Evolocumab in Patients without a Previous Myocardial Infarction or Stroke.
    N Engl J Med. 2025 Nov 8. doi: 10.1056/NEJMoa2514428.
    

    >> Share

    
    

    
    Nat Genet

51. SOREMEKUN O, Park YC, Tutino M, Arruda AL, et al
    Linking the plasma proteome to genetics in individuals from continental Africa provides insights into type 2 diabetes pathogenesis.
    Nat Genet. 2026 Jan 8. doi: 10.1038/s41588-025-02421.
    

    >> Share

    
    

    
    PLoS One

52. AMARE F, Kiflu A, Taddese A
    Impact of exercise sequence in concurrent training on insulin resistance, glycemic control, and blood pressure in Type 2 diabetes.
    PLoS One. 2026;21:e0340587.
    

    >> Share

    
    
53. NONG VD, Nguyen DQ, Do TT, Giang Tran TH, et al
    Identification of stable internal reference genes for expression analysis in the liver and pancreas of diabetic mouse (Mus musculus L.) models under physiological, pathological and treatment conditions.
    PLoS One. 2026;21:e0338403.
    

    >> Share

    
    
54. ELKENAWY EM, Khodadadi N, Gaber KS, Khodadadi E, et al
    Automated retinal disease classification using deep learning and AlexNet with statistical models analysis.
    PLoS One. 2026;21:e0338415.
    

    >> Share

    
    
55. HERRAIZ-ADILLO A, Radholm K, Iredahl F, Carlhall CJ, et al
    Validity of the International Fitness Scale (IFIS) and its associations with cardiometabolic health and body composition in adults with type 2 diabetes: A cross-sectional study.
    PLoS One. 2026;21:e0339364.
    

    >> Share

    
    
56. 
    Expression of Concern: Quality of information in gestational diabetes mellitus videos on TikTok: Cross-sectional study.
    PLoS One. 2026;21:e0340234.
    

    >> Share

    
    
57. WESTALL SJ, Watmough S, Narayanan RP, Irving G, et al
    Feasibility of glycated haemoglobin target-setting in adults with diabetes: A mixed-methods study.
    PLoS One. 2026;21:e0317162.
    

    >> Share

    
    

    
    Proc Natl Acad Sci U S A

58. CHEN C, Zhu L, Li W, Jiang Y, et al
    Hyperglycemia promotes SIRT3-mediated deacetylation of SARM1 to exacerbate diabetic peripheral neuropathy in mice.
    Proc Natl Acad Sci U S A. 2026;123:e2517110123.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share